Literature DB >> 17294147

[Clopidogrel versus acetylsalicylic acid in the secondary prophylaxis of vascular diseases. A commentary on the report of the Institute for Quality and Efficiency in the Health Service].

Heinrich Mattle, K Niederkorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17294147     DOI： 10.1007/s00115-007-2258-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  6 in total

1.  Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.

Authors:  Deepak L Bhatt; Steven P Marso; Alan T Hirsch; Peter A Ringleb; Werner Hacke; Eric J Topol
Journal:  Am J Cardiol       Date:  2002-09-15       Impact factor: 2.778

2.  European Stroke Initiative Recommendations for Stroke Management-update 2003.

Authors:  Tom Skyhoj Olsen; Peter Langhorne; Hans Christoph Diener; Michael Hennerici; Jose Ferro; Johani Sivenius; Nils Gunnar Wahlgren; Philip Bath
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

3.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.

Authors:  Ralph L Sacco; Robert Adams; Greg Albers; Mark J Alberts; Oscar Benavente; Karen Furie; Larry B Goldstein; Philip Gorelick; Jonathan Halperin; Robert Harbaugh; S Claiborne Johnston; Irene Katzan; Margaret Kelly-Hayes; Edgar J Kenton; Michael Marks; Lee H Schwamm; Thomas Tomsick
Journal:  Stroke       Date:  2006-02       Impact factor: 7.914

4.  Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.

Authors:  D L Bhatt; D P Chew; A T Hirsch; P A Ringleb; W Hacke; E J Topol
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

5.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

6.  Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.

Authors:  Peter A Ringleb; Deepak L Bhatt; Alan T Hirsch; Eric J Topol; Werner Hacke
Journal:  Stroke       Date:  2004-01-22       Impact factor: 7.914
  6 in total
  2 in total

1.  [Secondary prevention of stroke according to PRoFESS and SPARCL].

Authors:  D Sander; T Etgen
Journal:  Internist (Berl)       Date:  2009-11       Impact factor: 0.743

Review 2.  [Current aspects of secondary prevention of ischemic stroke].

Authors:  R Weber; H C Diener; M Grond
Journal:  Nervenarzt       Date:  2007-10       Impact factor: 1.214
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.